Markus S. Kupka

Markus S. Kupka

Auto-generated profile, based on publicly available information

Markus S. Kupka

Department of Obstetrics and Gynecology, University Hospital, LMU Munich, Munich, Germany; Reproductive Medicine Center - Gynaekologicum, Hamburg, Germany

Research Focus & Metrics

Academic Career Length

24Years (2003-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
10 July 2024 in Fertility and Sterility
Verified
Journal Article
Open access
MKMarkus S. Kupka
Markus S. Kupka
GCGeorgina M. Chambers
Georgina M. Chambers
SDSilke Dyer
Silke Dyer
FZFernando Zegers-Hochschild
Fernando Zegers-Hochschild
JMJacques de Mouzon
Jacques de Mouzon
GAG. David Adamson
G. David Adamson
To report utilization, effectiveness, and safety of assisted reproductive technologies in 2015 and 2016. Retrospective, cross-sectional survey of 3103 assisted reproductive technology clinics in 74 countries in 2015 and 3249 clinics in 79 countries in 2016 that submitted cycle and pregnancy outcome data through national and regional registries. Patients undergoing assisted reproductive technology procedures. Assisted reproductive technology. Outcomes on country, regional, and global levels. Reported for 2015: 2,358,239 cycles with 548,652 babies born; for 2016: 2,807,963 cycles with 647,188 babies born. Estimated in 2015, ≥2,683,677 cycles resulted in >675,134 babies; in 2016, ≥3,100,448 cycles resulted in ≥723,026 babies. Reported cycles represent approximately 80% of global utilization. In 2015 and 2016, 27.6% and 27.8%, respectively, of women undergoing fresh autologous cycles were age ≥40 years. Frozen-thawed embryo transfer cycles accounted for 47.0% and 51.9%, respectively, of all embryo transfers in 2015 and 2016. Oocyte donation cycles accounted for 6.7% and 7.1% of all embryo transfers in 2015 and 2016. Intracytoplasmic sperm injection was performed in 57.7% and 56.4% of autologous aspiration cycles in 2015 and 2016, respectively. The cumulative delivery rate per aspiration cycle for fresh and frozen-thawed embryo transfer was 32.4% in 2015 and 33.1% in 2016, respectively. The average number of transferred embryos was 1.70 in 2015 and 1.69 in 2016. The proportion of single embryo transfers in fresh autologous cycles increased from 42.1% in 2015 to 44.0% in 2016. The twin delivery rate decreased from 16.0% in 2015 to 14.7% in 2016, and the triplet rate decreased from 0.6% in 2015 to 0.4% in 2016. The proportion of single embryo transfers in frozen-thawed embryo transfer autologous cycles was 62.2% in 2015 and 64.2% in 2016, with twin and triplet rates of 10.1% and 0.3% in 2015 and 10.0% and 0.2% in 2016, respectively. Utilization of assisted reproductive technology and births per cycle increased from 2015 to 2016 while multiple births were reduced . Increasing proportion of frozen-thawed embryo transfer cycles, continuing wide variation in use of intracytoplasmic sperm injection, and increase in single embryo transfer rates are reported.

1 November 2006 in Fertility and Sterility
Verified
Journal Article
Open access
PDF file
Ioannis MylonasIoannis Mylonas
Ioannis Mylonas
Udo JeschkeUdo Jeschke
Udo Jeschke
CKChristiane Kunert-Keil
Christiane Kunert-Keil
NSNaim Shabani
Naim Shabani
DDDarius Dian
Darius Dian
KFKlaus Friese
Klaus Friese
Glycodelin, formerly named placental protein 14 (PP14), is an approximately 28-kDa glycoprotein with a unique carbohydrate configuration, consistent with sialylated GalNAc1-4GlcNAc (LacdiNAc) structures that are very unusual for mammals ( 1 x 1 Dell, A., Morris, H.R., Easton, R.L., Panico, M., Patankar, M., Oehniger, S. et al. Structural analysis of the oligosaccharides derived from glycodelin, a human glycoprotein with potent immunosuppressive and contraceptive activities. J Biol Chem. 1995; 270: 24116–24126 Crossref | PubMed | Scopus (143) | Google Scholar See all References 1 ). Glycodelin, isolated from amniotic fluid (glycodelin A), is composed of two identical subunits that are connected closely by noncovalent bonds and have a carbohydrate content of 17.5%, with a unique carbohydrate configuration ( 2 x 2 Bohn, H., Kraus, W., and Winckler, W. New soluble placental tissue proteins: their isolation, characterization, localization and quantification. Placenta Suppl. 1982; 4: 67–81 PubMed | Google Scholar See all References 2 ).

23 January 2003 in Archives of Gynecology and Obstetrics
Verified
Journal Article
Closed access
PDF file
OROtto Richter
Otto Richter
WPW. Petrow
W. Petrow
EWEva Wardelmann
Eva Wardelmann
CDC. Dorn
C. Dorn
MKM. Kupka
M. Kupka
UUU. Ulrich
U. Ulrich

1 June 2023 in Human Reproduction
Verified
Journal Article
Open access
PDF file
GAG D Adamson
G D Adamson
SDS Dyer
S Dyer
FZF Zegers-Hochschild
F Zegers-Hochschild
GCG Chambers
G Chambers
JMJ De Mouzon
J De Mouzon
SJS C Jwa
S C Jwa
Title: International Committee for Monitoring Assisted Reproductive Technologies (ICMART) Preliminary World Report on ART, 2019 Study question: In 2019 what was the global utilization, effectiveness and safety of ART? Summary answer: Globally, ART utilization and data collection continue to increase but with wide variations in utilization, effectiveness and safety. What is known already: ICMART began ART global data collection in 1991. Utilization, effectiveness and safety have continuously improved with more cycles, higher pregnancy rates and lower multiple birth rates, the latter due to the transfer of fewer embryos. Frozen embryo transfer (FET) and donor egg cycles continue to increase. However, wide variations in practice and outcomes exist globally. Approximately 10 million ART babies have been born. ICMART has helped develop registries internationally. A new electronic data collection platform has been developed with the University of New South Wales (UNSW) in Sydney, Australia; nevertheless, data collection and quality remain challenging. Study design, size, duration: Countries and regions annually collect ART data, some prospectively and others retrospectively. ICMART retrospectively requested data from all known global sources for 2019 and reviewed them for missing or incorrect data. The dataset was reviewed and corrected by ICMART, in partnership with UNSW for validation and analysis, then ICMART finalized the results tables. Standardized definitions from The International Glossary on Infertility and Fertility Care, 2017, and previously developed methods were used. Preliminary results are presented. Participants/materials, setting, methods: The European IVF Monitoring Consortium (EIM), Latin American Network of Assisted Reproduction (REDLARA), Australian/ New Zealand Registry and African Network and Registry for ART (ANARA) submitted regional data, and other countries contributed national data, through standardized formats, to ICMART. A few individual clinics with no registry access also contributed. Data received were reviewed, corrected, and validated to the extent possible, analyzed and summarized by ICMART using descriptive statistics. Main results and the role of chance: Data collection and analysis are ongoing, so the presented results are preliminary. The number of ART cycles continues to increase, but utilization is still highly variable among countries and regions. Regional and country differences persist in the age of women treated, number of embryos transferred, live birth rates, rate of multiple births, use of ICSI, cryopreservation cycles and other factors. The role of chance is minimal. Actual global ART results are limited to reporting countries and clinics representing 90 to 95% of global cycles. However, this is a very large sample size from which imputation of total global results is performed. Limitations, reasons for caution: Most, but not all, countries report to ICMART. Some countries have limited data and many countries have limited data validation. ICMART can perform only minimal verification of submitted data. Widespread adherence to consensus definitions provided in the Glossary takes time and requires translation into multiple languages. Standardization of validation and reporting is an ongoing process because of missing data and continuing changes in clinical practice. Wider implications of the findings: ICMART World Reports standardize data, track trends, enable comparisons, stimulate questions and improve ART quality. Better understanding of ART increases societal acceptance and support for equitable access and ART research.

1 January 2008
Verified
Book Chapter
Closed access
WJWolfgang Janni
Wolfgang Janni
BRBrigitte Rack
Brigitte Rack
KFKlaus Friese
Klaus Friese
CDChristian Dannecker
Christian Dannecker
FKFranz Edler von Koch
Franz Edler von Koch
JHJens Bodo Huober
Jens Bodo Huober

1 January 2016
Verified
Book Chapter
Closed access
MKMarkus S. Kupka
Markus S. Kupka